Engineering of mucin-type human glycoproteins in yeast cells

Mucin-type O-glycans are the most typical O-glycans found in mammalian cells and assume many different biological roles. Here, we report a genetic engineered yeast strain capable of producing mucin-type sugar chains. Genes encoding Bacillus subtilis UDP-Gal/GalNAc 4-epimerase, human UDP-Gal/GalNAc transporter, human ppGalNAc-T1, and Drosophila melanogaster core1 β1–3 GalT were introduced into Saccharomyces cerevisiae. The engineered yeast was able to produce a MUC1a peptide containing O-glycan and also a mucin-like glycoprotein, human podoplanin (hPod; also known as aggrus), which is a platelet-aggregating factor that requires a sialyl-core1 structure for activity. After in vitro sialylation, hPod from yeast could induce platelet aggregation. Interestingly, substitution of ppGalNAc-T1 for ppGalNAc-T3 caused a loss of platelet aggregation-inducing activity, despite the fact that the sialyl-core1 was detectable in both hPod proteins on a lectin microarray. Most of O-mannosylation, a common modification in yeast, to MUC1a was suppressed by the addition of a rhodanine-3-acetic acid derivative in the culture medium. The yeast system we describe here is able to produce glycoproteins modified at different glycosylation sites and has the potential for use in basic research and pharmaceutical applications.

[1]  K. Mishima,et al.  Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression , 2006, Acta Neuropathologica.

[2]  A. Kuno,et al.  Inhibition of tumor cell-induced platelet aggregation using a novel anti-podoplanin antibody reacting with its platelet-aggregation-stimulating domain. , 2006, Biochemical and biophysical research communications.

[3]  G. Ashwell,et al.  Carbohydrate-specific receptors of the liver. , 1982, Annual review of biochemistry.

[4]  T. Tsuruo,et al.  Molecular Identification of Aggrus/T1α as a Platelet Aggregation-inducing Factor Expressed in Colorectal Tumors* , 2003, Journal of Biological Chemistry.

[5]  R. Cummings,et al.  A unique molecular chaperone Cosmc required for activity of the mammalian core 1 β3-galactosyltransferase , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[6]  A. Kuno,et al.  Evanescent-field fluorescence-assisted lectin microarray: a new strategy for glycan profiling , 2005, Nature Methods.

[7]  R. Bast,et al.  Monoclonal antibody immunoradiometric assay for an antigenic determinant (CA 125) associated with human epithelial ovarian carcinomas. , 1984, Cancer research.

[8]  M. Orchard,et al.  Rhodanine-3-acetic acid derivatives as inhibitors of fungal protein mannosyl transferase 1 (PMT1). , 2004, Bioorganic & medicinal chemistry letters.

[9]  Y. Hiki,et al.  Protective role of IgA1 glycans against IgA1 self-aggregation and adhesion to extracellular matrix proteins. , 1998, Journal of the American Society of Nephrology : JASN.

[10]  E. Tian,et al.  A UDP-GalNAc:Polypeptide N-Acetylgalactosaminyltransferase Is Required for Epithelial Tube Formation* , 2007, Journal of Biological Chemistry.

[11]  T. Hennet,et al.  Characterization of mucin‐type core‐1 β1‐3 galactosyltransferase homologous enzymes in Drosophila melanogaster , 2005, The FEBS journal.

[12]  Yu-Teh Li.  Studies on the Glycosidases in Jack Bean Meal I. ISOLATION AND PROPERTIES OF α-MANNOSIDASE , 1967 .

[13]  Kazuo Kobayashi,et al.  Efficient Antibody Production upon Suppression of O Mannosylation in the Yeast Ogataea minuta , 2007, Applied and Environmental Microbiology.

[14]  D. Karamata,et al.  The Bacillus subtilis Gne (GneA, GalE) protein can catalyse UDP-glucose as well as UDP-N-acetylglucosamine 4-epimerisation. , 2003, Gene.

[15]  A. Helenius,et al.  Intracellular functions of N-linked glycans. , 2001, Science.

[16]  S. Munro,et al.  Multi‐protein complexes in the cis Golgi of Saccharomyces cerevisiae with α‐1,6‐mannosyltransferase activity , 1998, The EMBO journal.

[17]  E. Bennett,et al.  cDNA cloning and expression of a novel human UDP-N-acetyl-alpha-D-galactosamine. Polypeptide N-acetylgalactosaminyltransferase, GalNAc-t3. , 1996, The Journal of biological chemistry.

[18]  H. Narimatsu,et al.  Initiation of O-Glycan Synthesis in IgA1 Hinge Region Is Determined by a Single Enzyme, UDP-N-Acetyl-α-d-galactosamine:PolypeptideN-Acetylgalactosaminyltransferase 2* , 2003, The Journal of Biological Chemistry.

[19]  岩崎 裕子.  Initiation of O-glycan synthesis in IgA1 hinge region is determined by a single enzyme, UDP-N-acetyl-α-D-galactosamine : Polypeptide N-acetylgalactosaminyltransferase 2 , 2003 .

[20]  P. Stanley,et al.  The Threonine That Carries Fucose, but Not Fucose, Is Required for Cripto to Facilitate Nodal Signaling* , 2007, Journal of Biological Chemistry.

[21]  Masao Kawakita,et al.  Human and Drosophila UDP-galactose transporters transport UDP-N-acetylgalactosamine in addition to UDP-galactose. , 2002, European journal of biochemistry.

[22]  Y. Ikehara,et al.  Cloning and expression of a human gene encoding an N-acetylgalactosamine-alpha2,6-sialyltransferase (ST6GalNAc I): a candidate for synthesis of cancer-associated sialyl-Tn antigens. , 1999, Glycobiology.

[23]  H. Bennett,et al.  Differential glycosylation of N‐POMC1–77 regulates the production of γ3‐MSH by purified pro‐opiomelanocortin converting enzyme A possible mechanism for tissue‐specific processing , 1991, FEBS letters.

[24]  Lawrence A Tabak,et al.  All in the family: the UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases. , 2003, Glycobiology.

[25]  S. Kawa,et al.  Clinical evaluation of pancreatic cancer-associated mucin expressing CA19-9, CA50, Span-1, sialyl SSEA-1, and Dupan-2. , 1992, Scandinavian journal of gastroenterology.

[26]  S. Wong-Madden,et al.  Purification and characterization of novel glycosidases from the bacterial genus Xanthomonas. , 1995, Glycobiology.

[27]  R. Sagi-Eisenberg,et al.  O-glycosylation is essential for intracellular targeting of synaptotagmins I and II in non-neuronal specialized secretory cells , 2005, Journal of Cell Science.

[28]  P. Singh,et al.  Cell surface-associated mucins in signal transduction. , 2006, Trends in cell biology.

[29]  Hiromi Ito,et al.  Molecular analysis of the pathophysiological binding of the platelet aggregation‐inducing factor podoplanin to the C‐type lectin‐like receptor CLEC‐2 , 2007, Cancer science.

[30]  Michael A. Hollingsworth,et al.  Mucins in cancer: protection and control of the cell surface , 2004, Nature Reviews Cancer.

[31]  L. Lichtenberger.  The hydrophobic barrier properties of gastrointestinal mucus. , 1995, Annual review of physiology.

[32]  A. Le Bivic,et al.  Apical Sorting by Galectin‐3‐Dependent Glycoprotein Clustering , 2007, Traffic.

[33]  M. Gentzsch,et al.  The PMT gene family: protein O‐glycosylation in Saccharomyces cerevisiae is vital. , 1996, The EMBO journal.

[34]  D. Goldenberg,et al.  Identification of a colon-specific antigen (CSA) in normal and neoplastic tissues. , 1975, Journal of immunology.

[35]  T. A. Fritz,et al.  Identification of Common and Unique Peptide Substrate Preferences for the UDP-GalNAc:Polypeptide α-N-acetylgalactosaminyltransferases T1 and T2 Derived from Oriented Random Peptide Substrates* , 2006, Journal of Biological Chemistry.

[36]  Terri L. Gilbert,et al.  Cloning and analysis of the Saccharomyces cerevisiae MNN9 and MNN1 genes required for complex glycosylation of secreted proteins. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[37]  S. Gendler,et al.  Epithelial mucin genes. , 1995, Annual review of physiology.

[38]  J. Paulson,et al.  Cloning and expression of the Gal beta 1, 3GalNAc alpha 2,3-sialyltransferase. , 1992, The Journal of biological chemistry.

[39]  E. Bennett,et al.  Purification and cDNA Cloning of a Human UDP-N-acetyl-α- D-galactosamine:polypeptide N-Acetylgalactosaminyltransferase (*) , 1995, The Journal of Biological Chemistry.

[40]  M. Hollingsworth,et al.  Substrate Specificities of Three Members of the Human UDP-N-Acetyl-α-d-galactosamine:Polypeptide N-Acetylgalactosaminyltransferase Family, GalNAc-T1, -T2, and -T3* , 1997, The Journal of Biological Chemistry.

[41]  Jack Hoopes,et al.  Humanization of Yeast to Produce Complex Terminally Sialylated Glycoproteins , 2006, Science.

[42]  P. Azadi,et al.  A Mutant Chaperone Converts a Wild-Type Protein into a Tumor-Specific Antigen , 2006, Science.

[43]  A. Kuno,et al.  Functional glycosylation of human podoplanin: Glycan structure of platelet aggregation‐inducing factor , 2007, FEBS letters.

[44]  H. Koprowski,et al.  Identification of the gastrointestinal and pancreatic cancer-associated antigen detected by monoclonal antibody 19-9 in the sera of patients as a mucin. , 1983, Cancer research.